Abstract:Background: Acute kidney injury (AKI) is one of the most common clinical emergencies characterized by rapid progression, difficulty in early diagnosis, and high mortality. Currently, there are no effective AKI early diagnostic methods and treatments. Therefore, identifying new mechanisms of AKI have become urgent for development new targets for early diagnosis and treatment of AKI in the current clinical setting. Methods: In this study, systematic analysis and comparison of serum metabolic profiles of clinical AKI patients, chronic kidney disease (CKD) patients, and healthy subjects were performed using untargeted metabolomics. Moreover, the first spatial metabolomic analysis of kidney tissues in an AKI mouse model using MALDI-TOF MS technology was conducted. Differentially expressed metabolites were identified using a comprehensive, publicly available database. The metabolic data obtained were evaluated using principal component analysis, (orthogonal) partial least squares discriminant analysis, and metabolic pathway analysis to explore the unique serum metabolic profile of the patients, as well as to characterize the spatial distribution of differential metabolites in the kidneys of AKI mice. Results: Significant changes in the metabolite levels of amino acids, carnitine, and lipids were observed in the AKI and CKD groups versus the healthy population, suggesting that kidney injury may lead to abnormalities in various metabolic pathways, such as amino acids, fatty acids, and lipids. The significant difference between the AKI and CKD groups were found for the first time in these indexes including amino acid, carnitine, fatty acid, and lipid levels. Additionally, spatial metabolomics results revealed that amino acid, carnitine, organic acid, and fatty acid metabolites were more likely significantly altered in the renal cortex, while lipid metabolites were both differentially distributed in the cortex and medulla of the AKI group. Conclusion: Abnormalities in the serum metabolism of amino acids, carnitine, and lipids in patients with kidney diseases, such as AKI and CKD, are closely associated with the physiological dysfunction of kidney injury. Metabolic differences between patients with AKI and CKD were compared for the first time, showing that fatty acid oxidative inhibition was more severe in patients with AKI. Furthermore, spatial metabolomics has revealed metabolic reprogramming with tissue heterogeneity in AKI mice model. Our study provides valuable information in the molecular pathological features of AKI in the kidney tissues.

Changes in aging-induced kidney dysfunction in mice based on a metabolomics analysis

Comparative Proteomic Analysis Identifies Biomarkers for Renal Aging.

Glutathione is an aging-related metabolic signature in the mouse kidney

Multi-omics reveals the role of MCM2 and hnRNP K phosphorylation in mouse renal aging through genomic instability

Serum Metabolomic Profiling in Aging Mice Using Liquid Chromatography—Mass Spectrometry

Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging

Oxidations and amino acid substitutions in urinary proteins are the distinguishing characteristics of aging

Metabolite accumulation from oral NMN supplementation drives aging-specific kidney inflammation

Integrated Transcriptome, Proteome, Acetylome, and Metabolome Profiling of Mouse Liver During Normal Aging

Identification of the Metabolic Signature of Aging Retina

Identification of Common and Differential Mechanisms of Glomerulus and Tubule Senescence in 24-Month-old Rats by Quantitative LC-MS/MS

Expression of Angiogenesis Regulatory Factors and Their Receptors in Mouse Kidneys with Aging

Alterations in the gut microbiome and metabolism profiles reveal the possible molecular mechanism of renal injury induced by hyperuricemia in a mouse model of renal insufficiency

The metabolic footprint of aging in mice

IDDF2020-ABS-0141 the Gut Microbiome and Serum Metabolome Orchestrate Healthy Aging and Longevity with Novel Implications for Renal Function

Untargeted and spatial-resolved metabolomics characterize serum and tissue-specific metabolic reprogramming in acute kidney injury

Single-cell transcriptome sequencing partially revealed the changes of T cells in the early stage of aging kidney

Multi-omics reveals aging-related pathway in natural aging mouse liver

Pathological mechanisms of kidney disease in ageing

Aging and senescence-associated analysis of the aged kidney glomerulus highlights the role of mesangial cells in renal aging

Alterations in bone metabolites with age in C57BL/6 mice model